Search for: "In re: Janssen Biotech, Inc."
Results 1 - 20
of 30
Sorted by Relevance
|
Sort by Date
15 May 2017, 9:50 pm
Patent and Trademark Office has now filed its response brief in In re: Janssen Biotech, Inc., New York University, No. 2017-1257 (Fed. [read post]
29 Jan 2018, 9:59 pm
Janssen Biotech, Inc. and New York University ("Janssen"), co-assignees of the '471 patent, argued on appeal that obviousness-type double patenting was not applicable because the safe-harbor provision of 35 U.S.C. [read post]
7 Nov 2008, 3:42 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: CAFC affirms rejection of claim reciting broad genus of monoclonal antibodies for failure to satisfy written description requirement: In… [read post]
2 Jul 2014, 1:42 pm
Janssen Biotech and Centocor Biologics (Fed. [read post]
5 Aug 2009, 5:35 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
10 Feb 2010, 4:47 pm
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
15 Dec 2010, 2:17 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
3 Mar 2010, 5:05 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
3 Mar 2010, 5:05 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
15 Jul 2009, 5:15 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
6 Oct 2017, 2:34 pm
Janssen Biotech Inc., 759 F.3d 1285 (Fed. [read post]
6 Oct 2017, 2:34 pm
Janssen Biotech Inc., 759 F.3d 1285 (Fed. [read post]
28 Apr 2015, 9:14 am
Janssen Biotech, Inc. [read post]
17 Mar 2022, 2:32 pm
Janssen Biotech, Inc., 759 F.3d 1285, 1300–01 (Fed. [read post]
8 Jan 2009, 4:07 am
Janssen LLP, 2008 WL 5413105 (D.N.J. [read post]
4 Jan 2024, 9:42 am
Janssen Biotech, Inc., 759 F.3d 1285 (Fed. [read post]
25 Nov 2009, 3:00 am
(IP finance) Australia Trade mark use: We need a more balanced solution – FCA decision in Alcon v Bausch & Lomb (Australian Trade Marks Law Blog) FCA on trade marks as security for costs: Austin, Nichols & Co Inc v Lodestar Anstalt (ipwars) Minister for Innovation decides not to change regulatory regime for books – publishers keep territorial exclusivity (LawFont) (Managing Intellectual Property) Non-English language publications may not be citable art: APO… [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP) Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) Events 26 August:… [read post]
